To investigate the clinical significance of CD9 and CD81 expression in HCC, two tissue microarrays containing 75 paired HCC tissues and adjacent normal tissues were analyzed using specific antibodies against CD9 or CD81 via immunohistochemical staining (IHC). This evidence concerns the gene CD9 and hepatocellular carcinoma.